Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg. The trial is designed to determine the safety and activity of a novel clot dissolving (thrombolytic) drug (alfimeprase).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ARCA Biopharma, Inc.
• Collaborator: Health Decisions

Criteria

• Patients with acute peripheral arterial occlusion of the lower limb (onset of symptoms within 14 days)

• Rutherford Class I or IIa (minimal sensory loss, no muscle weakness, audible venous flow)

• Age 18 or above

• Able to consent

• Able to follow up